Loading...
NPI 1023151644 · Saint George, UT · Pain Medicine (Anesthesiology) Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Spencer Wells is a pain medicine (anesthesiology) physician provider located in Saint George, Utah. This profile covers 31 Medicare and 5 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Spencer Wells |
| Address | 617 E Riverside Dr Ste 301 |
| City | Saint George |
| State | UT |
| ZIP | 84790 |
| Taxonomy | Pain Medicine (Anesthesiology) Physician |
| NPI Enumerated | February 14, 2007 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $596.1K |
| Medicaid | $19.1K |
Practice profile and tenure: SPENCER WELLS is an established Pain Medicine (Anesthesiology) physician with an NPI enumerated on 2007-02-14 (~19 years ago), indicating long-standing Medicare/Medicaid participation and likely sustained local referral relationships in Saint George, UT. The clinical mix and billing patterns align with a procedural interventional pain practice rather than a primary-care model.
Service-line focus driven by top Medicare procedures: Medicare revenue is concentrated in interventional spine and pain procedures — the top Medicare revenue-driving codes include 64483, 22514, and 64635, which together account for 31.5% of this provider's total Medicare revenue. These codes reflect frequent use of transforaminal epidural injections, percutaneous vertebral augmentation (kyphoplasty), and neurolytic facet/nerve procedures, signaling an operational emphasis on image-guided spine interventions and procedural pain management.
Revenue concentration and payer mix: The provider reports $596.1K in lifetime Medicare revenue versus $19.1K in lifetime Medicaid revenue, so Medicare dominates the revenue stream and the practice is effectively Medicare-focused at scale. On Medicaid the billing is narrowly concentrated — the precomputed top 3 Medicaid codes account for 100.0% of Medicaid revenue — indicating the practice sees Medicaid patients primarily for office evaluation-and-management visits rather than the higher-revenue interventional procedures billed to Medicare.
Medicare competitive standing: For many of the interventional codes this provider bills at or above typical national volumes — for example, 62323 ranks in the 96th percentile and 62321 ranks in the 97th percentile (both noted as "notably above typical national volume"), and several facet/joint codes (64484, 64494, 99152) also appear in the upper percentiles. At the same time other high-revenue codes like 64483 and 64635 are characterized as typical/unremarkable volumes nationally (94th and 91st percentiles respectively), so the provider is a prominent regional performer on some specific injection procedures but not uniformly dominant across all procedure types.
Notable statistical outliers and supply billing: J3301 (triamcinolone acetonide) is an extreme outlier in national ranking with 7.4K claims producing $7.4K revenue and is flagged as "extreme outlier, far above typical national volume." This suggests exceptionally high unit counts for a low-unit-price drug code relative to peers and is a distinctive feature of this provider's Medicare billing mix.
Use of ancillary monitoring and safety codes: Definitive drug testing codes G0482 and G0483 together represent meaningful Medicare revenue share (G0482 at 9.5% and G0483 at 3.6% of Medicare revenue) and support a practice pattern that includes drug monitoring and toxicology services typical of interventional pain management. The presence of signed opioid treatment agreement and pain-assessment codes in the Medicaid file (G9578, G8730) — even where they show $0 paid — indicates documentation and quality measure activity consistent with opioid-risk management workflows.
Medicaid billing profile is office-visit centric: Medicaid billing is overwhelmingly for evaluation-and-management visits, with 99213 alone accounting for $18.3K (95.8% of Medicaid revenue) and 99214 adding $812 (4.2% of Medicaid revenue). This contrasts with Medicare, where procedural, image-guided spine interventions and diagnostic testing drive revenue, showing a payer-based split in service mix offered to patients.
Operational implication for payers and network planners: The combination of concentrated Medicare procedural revenue (31.5% from the top three Medicare codes), high-volume injection and neurolysis procedures, substantial toxicology testing, and virtually all Medicaid revenue coming from 99213/99214 suggests this provider functions as a procedure-centric pain practice that treats Medicare populations with image-guided interventions while managing Medicaid patients largely through office visits and documentation-driven quality measures.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
31 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 64483 | This procedure is the injection of an anesthetic agent and/or steroid in the form of a transforaminal epidural injection into a single level (either lumbar or sacral). | 310 | $210 | $65.1K |
| 22514 | The provider performs a percutaneous vertebral augmentation of the lumbar spine, such as kyphoplasty, a surgical procedure that treats compression fractures of the spine. He also may perform a… | 10 | $4,460 | $62.4K |
| 64635 | Under fluoroscopic or CT guidance, the provider applies an agent to a lower back joint to destroy nerve tissue. | 120 | $500 | $60.2K |
| 62323 | The provider injects a diagnostic or a therapeutic substance, such as pain medication or a steroid, into the space around the spinal nerves of the lumbar (lower back) or sacral (caudal, or tailbone)… | 310 | $190 | $59.8K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 290 | $200 | $56.7K |
| 64636 | In this add on procedure, the provider destroys the facet joint nerve of a lumbar or sacral spinal segment using neurolytic agents like heat, electric current, or a chemical compound. He makes use of… | 120 | $280 | $32.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 340 | $90 | $30.5K |
| 64493 | The provider injects a diagnostic or therapeutic substance into a single lumbar or sacral paravertebral facet (zygapophyseal) joint, or into the nerves that supply that joint, using imaging guidance… | 150 | $200 | $30.1K |
| 62321 | The provider injects a diagnostic or a therapeutic substance, such as pain medication or a steroid, into the space around the spinal nerves of the cervical (neck) or thoracic (upper and middle back)… | 130 | $190 | $24.7K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 90 | $240 | $21.3K |
Showing 1–10 of 31
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 31 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
31 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 63650 | 18 | 20 | 50 | $1,750 | $124.6K |
| 22514 | 3 | 10 | 20 | $4,320 | $73.4K |
| G0483 | 5 | 20 | 60 | $240 | $54.2K |
| G0482 | 3 | 20 | 70 | $180 | $20.2K |
| 64635 | 6 | 80 | 50 | $350 | $20.1K |
| 62323 | 6 | 80 | 60 | $170 | $18.4K |
| 64483 | 4 | 100 | 50 | $190 | $16K |
| 99214 | 441 | 4,080 | 80 | $80 | $11.6K |
| 64493 | 3 | 70 | 50 | $170 | $10.6K |
| 62321 | 6 | 50 | 50 | $180 | $9.7K |
Showing 1–10 of 31
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
5 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 370 | $50 | $18.3K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 10 | $60 | $810 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 620 | $0 | $0 |
| G8730 | Pain assessment documented as positive using a standardized tool and a follow-up plan is documented | 300 | $0 | $0 |
| G9578 | Documentation of signed opioid treatment agreement at least once during opioid therapy | 10 | $0 | $0 |
How this provider's Medicaid billing volume and revenue compare to other Utah providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Utah median
5 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,207 | 1,340 | 200 | $80 | $144K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 506 | 1,360 | 190 | $70 | $125K |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 16 | 60 | 200 | $1 | $530 |
| G8730 | Pain assessment documented as positive using a standardized tool and a follow-up plan is documented | 3 | 10 | 190 | $1 | $40 |
| G9578 | Documentation of signed opioid treatment agreement at least once during opioid therapy | 3 | 10 | 80 | $1 | $40 |
Other providers in the same ZIP code as Spencer Wells, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.